NCT00118417View on ClinicalTrials.gov

Therapies for Treatment-Resistant Panic Disorder Symptoms

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Panic Disorder
Interventions
DRUG

Clonazepam

Participants will receive clonazepam.

DRUG

Sertraline

Participants will receive sertraline.

BEHAVIORAL

Cognitive behavioral therapy

Participants will receive cognitive behavioral therapy

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00118417 - Therapies for Treatment-Resistant Panic Disorder Symptoms | Biotech Hunter | Biotech Hunter